KR20200101114A - Food composition comprising Chrysanthemum zawadskii var extract - Google Patents
Food composition comprising Chrysanthemum zawadskii var extract Download PDFInfo
- Publication number
- KR20200101114A KR20200101114A KR1020190019342A KR20190019342A KR20200101114A KR 20200101114 A KR20200101114 A KR 20200101114A KR 1020190019342 A KR1020190019342 A KR 1020190019342A KR 20190019342 A KR20190019342 A KR 20190019342A KR 20200101114 A KR20200101114 A KR 20200101114A
- Authority
- KR
- South Korea
- Prior art keywords
- gujeolcho
- extract
- fatigue
- present
- stems
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 93
- 239000000203 mixture Substances 0.000 title claims description 25
- 235000013305 food Nutrition 0.000 title abstract description 16
- 241001331134 Chrysanthemum zawadskii Species 0.000 title abstract 2
- 235000018947 Chrysanthemum zawadskii Nutrition 0.000 title abstract 2
- 230000036541 health Effects 0.000 claims abstract description 24
- 235000013376 functional food Nutrition 0.000 claims abstract description 21
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 abstract description 6
- 238000009825 accumulation Methods 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 40
- 206010016256 fatigue Diseases 0.000 description 26
- 230000000694 effects Effects 0.000 description 17
- 230000036542 oxidative stress Effects 0.000 description 16
- 238000002835 absorbance Methods 0.000 description 14
- 239000000843 powder Substances 0.000 description 13
- 210000000663 muscle cell Anatomy 0.000 description 11
- 239000003642 reactive oxygen metabolite Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 10
- 210000003098 myoblast Anatomy 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 230000002292 Radical scavenging effect Effects 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 5
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 5
- 235000005493 rutin Nutrition 0.000 description 5
- 229960004555 rutoside Drugs 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- -1 lipid peroxides Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CCTFAOUOYLVUFG-UHFFFAOYSA-N 2-(1-amino-1-imino-2-methylpropan-2-yl)azo-2-methylpropanimidamide Chemical compound NC(=N)C(C)(C)N=NC(C)(C)C(N)=N CCTFAOUOYLVUFG-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000007976 Chrysanthemum zawadskii subsp latilobum Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 208000027499 body ache Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 피로를 개선할 수 있는 구절초 추출물을 유효성분으로 함유하는 건강기능식품에 관한 것이다.The present invention relates to a health functional food containing an extract of Gujeolcho that can improve fatigue as an active ingredient.
피로는 육체적 피로와 정신적 피로로 나눌 수 있고, 정상의 경우 7~9시간의 휴식에 의해 쉽게 없어지나, 피로가 과도하게 누적된 경우 수면이나 휴식만으로는 쉽게 풀리지 않는다.Fatigue can be divided into physical fatigue and mental fatigue, and in the normal case, it is easily eliminated by 7 to 9 hours of rest, but when fatigue is excessively accumulated, it is not easily resolved by sleep or rest alone.
불규칙적으로 장기간 과도하게 유발되는 육체적 피로는 근과 골격계의 성능 저하로 이어지고, 근육통, 몸살, 졸림 현상 등 다양하게 나타나며 정신적 피로 증상을 동반한 만성피로 증후군을 유발할 수 있다. Physical fatigue, which is caused irregularly and excessively for a long period of time, leads to deterioration of the performance of the muscular and skeletal system, and various symptoms such as muscle pain, body aches, and sleepiness may occur, and may cause chronic fatigue syndrome accompanied by mental fatigue symptoms.
바쁜 생활 속의 현대인들은 활동량의 부족, 정신적인 스트레스, 게으른 습관 및 비만 등으로 인해 피로가 쉽게 나타나, 질병 없이 건강을 유지하고자 하는 관심과 욕구는 점점 높아지고 있다.Modern people in a busy life are easily fatigued due to lack of activity, mental stress, lazy habits, and obesity, and the interest and desire to maintain health without disease is increasing.
일반적으로 육체적 피로는 과도한 운동이나 육체노동으로 초래되며, 이는 과도한 에너지 대사로 인한 산화적 스트레스로부터 활성산소종의 증가, 지질 과산화물 축적 등의 요인으로 근육세포의 손상을 초래함으로써, 젖산(lactate)의 생성과 축적으로 인하여 피로를 유발하게 된다. 그러므로 산화적 스트레스로부터 방어할 수 있는 에너지원 보충과 피로물질 누적을 감소시키는 것이 대표적인 피로개선 효과로 간주할 수 있다. In general, physical fatigue is caused by excessive exercise or physical labor, which causes damage to muscle cells due to factors such as increase of reactive oxygen species, accumulation of lipid peroxides, etc. from oxidative stress caused by excessive energy metabolism, and thus lactic acid is produced. It causes fatigue due to formation and accumulation. Therefore, supplementation of energy sources that can protect against oxidative stress and reduction of accumulation of fatigue substances can be regarded as typical fatigue improvement effects.
이에, 만성피로에 시달리는 현대인들은 피로회복과 건강증진 및 질병예방을 위한 영양물질을 보충하고자 건강기능식품의 섭취를 선호하고 있는 실정이다.Accordingly, modern people suffering from chronic fatigue prefer to consume health functional foods to supplement nutrients for fatigue recovery, health promotion, and disease prevention.
한편, 구절초는 항당뇨 등 효과가 알려져 있을 뿐으로 피로개선 관련 효능이 알려져 있지 않은 실정이다. 이에 본 발명에서는 구절초 추출물을 마우스 유래 근아세포에 처리하여 산화적 스트레스를 유발 후 근육세포 보호효과를 확인하였으며, 이를 바탕으로 본 발명은 구절초 추출물을 이용하여 피로개선용 건강기능성식품을 제공하고자 한다.On the other hand, Gujeolcho has only known effects such as anti-diabetes, and the effects related to fatigue improvement are not known. Accordingly, in the present invention, the extract of Gujeolcho was treated on mouse-derived myoblasts to induce oxidative stress and then the protective effect of muscle cells was confirmed. Based on this, the present invention intends to provide a health functional food for improving fatigue using Gujeolcho extract.
본 발명의 목적은 피로를 개선시킬 수 있는 구절초의 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 유효성분으로 함유하는 건강기능식품을 제공하는데 있다.An object of the present invention is to provide a health functional food containing a mixed extract of Gujeolcho flowers, stems, and roots that can improve fatigue as an active ingredient.
상기한 목적을 달성하기 위한 본 발명의 피로를 개선시킬 수 있는 건강기능식품은 구절초의 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 유효성분으로 함유할 수 있다.Health functional food that can improve the fatigue of the present invention to achieve the above object may contain a mixed extract of Gujeolcho flower, stem and root mixed as an active ingredient.
상기 구절초 혼합 추출물은 구절초의 꽃, 줄기 및 뿌리를 1 : 1-3 : 0.5-1의 중량비로 혼합한 것일 수 있다.The Gujeolcho mixed extract may be obtained by mixing the flowers, stems, and roots of Gujeolcho in a weight ratio of 1: 1-3: 0.5-1.
본 발명의 구절초 혼합 추출물을 유효성분으로 함유하는 건강기능식품은 피로개선 효과가 우수하다. Health functional food containing the Gujeolcho mixed extract of the present invention as an active ingredient is excellent in fatigue improvement effect.
특히, 구절초는 천연 약용식물로서 식용이 가능하므로 이로부터 유래한 추출물을 유효성분으로 포함하는 본 발명의 조성물은 장기간 사용에도 안전한 이점을 가진다.In particular, Gujeolcho is a natural medicinal plant and can be edible, so the composition of the present invention comprising an extract derived therefrom as an active ingredient has a safe advantage even for long-term use.
도 1은 본 발명의 구절초 혼합 추출물을 사용 시 근아세포에서 활성산소에 대한 형광 광도를 나타낸 그래프이다.1 is a graph showing the fluorescence intensity of reactive oxygen species in myoblasts when using the Gujeolcho mixed extract of the present invention.
본 발명은 피로를 개선시킬 수 있도록 구절초 추출물을 유효성분으로 함유하는 건강기능식품에 관한 것이다.
The present invention relates to a health functional food containing Gujeolcho extract as an active ingredient to improve fatigue.
이하, 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명의 피로를 개선시킬 수 있는 건강기능식품은 구절초의 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 유효성분으로 함유한다.The health functional food capable of improving fatigue of the present invention contains a mixed extract of Gujeolcho flowers, stems and roots as an active ingredient.
본 발명에 사용되는 구절초(Chrysanthemum zawadskii var. latilobum (Maxim.) Kitam.)는 국화과의 다년생 초본으로 야국(野菊), 선모초(仙母草), 고봉(苦蓬), 들국화라고도 한다. 전국 각처의 산지와 고원지에서 자생하고 중국, 러시아, 몽골, 일본 등지에서 자라며 민간에서 줄기와 잎을 가을에 채취하여 환의 형태, 혹은 달여서 부인 대부증 또는 건위제로 사용하여 왔다. 땅 속의 뿌리줄기가 옆으로 뻗으면서 번식하며, 개화기는 8-10월이며 결실기는 10-11월이다. 구절초 전초의 생약명은 선모초, 구절초라 하며, 꽃은 단아하고 아름다워 경관조성용으로 널리 재배되고 있다. 구절초 전초와 꽃 이삭은 폐렴, 기관지염, 기침, 감기, 부인병, 냉증, 위장병 및 고혈압 등에 사용되어 왔다. Gujeolcho ( Chrysanthemum zawadskii var.latilobum (Maxim.) Kitam.) used in the present invention is a perennial herb of the chrysanthemum family, and is also referred to as yaguk (野菊), sunmocho (仙母草), gobong (苦蓬), wild chrysanthemum. It grows wildly in mountainous and highlands nationwide, and grows in China, Russia, Mongolia, and Japan, and has been used in the form of a pill or decoction in the form of a pill after collecting stems and leaves in the private sector in the fall. It reproduces while the rootstock in the ground extends sideways, and the flowering period is August-October and the fruiting period is October-November. The herbal names of Gujeolcho outpost are called Seonmocho, Gujeolcho, and the flowers are elegant and beautiful, so they are widely cultivated for landscape creation. Gujeolcho outpost and flower spikes have been used for pneumonia, bronchitis, cough, cold, women's disease, poor circulation, gastrointestinal disease and high blood pressure.
본 발명에 따른 구절초 추출물은 구절초의 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물로서, 상기 구절초 혼합 추출물은 구절초의 꽃, 줄기 및 뿌리를 1 : 1-3 : 0.5-1의 중량비, 바람직하게는 1 : 1-2 : 0.6-0.8의 중량비로 혼합하여 추출한 것이다. 구절초의 꽃을 기준으로 줄기 및 뿌리의 함량이 상기 범위를 벗어나는 경우에는 피로개선의 효과가 저조할 수 있다.Gujeolcho extract according to the present invention is a mixed extract of Gujeolcho flowers, stems and roots mixed, the Gujeolcho mixed extract is the flowers, stems and roots of Gujeolcho in a weight ratio of 1: 1-3: 0.5-1, preferably 1 : 1-2: extracted by mixing at a weight ratio of 0.6-0.8. If the content of the stem and root based on the flower of Gujeolcho is outside the above range, the effect of improving fatigue may be poor.
본 발명의 구절초 혼합 추출물을 사용하지 않고, 구절초 꽃 추출물, 구절초 줄기 추출물 또는 구절초 뿌리 추출물을 사용하는 경우에는 구절초 혼합 추출물에 비하여 피로개선 효과가 현저히 저하될 수 있다. 특히, 구절초 꽃 추출물은 피로개선 효과가 거의 발생하지 않는다.When the Gujeolcho mixed extract of the present invention is not used, and a Gujeolcho flower extract, a Gujeolcho stem extract, or a Gujeolcho root extract is used, the fatigue improvement effect may be significantly reduced compared to the Gujeolcho mixed extract. In particular, Gujeolcho flower extract hardly causes fatigue improvement effect.
본 발명의 추출물은 60 내지 90 ℃에서 5 내지 10시간, 바람직하게는 7 내지 8시간 동안 추출한 추출물이다. 추출 온도 및 시간이 상기 하한치 미만인 경우에는 유효성분이 추출되지 않을 수 있으며, 상기 상한치 초과인 경우에는 탄맛이 강하고 영양성분이 파괴될 수 있다. The extract of the present invention is an extract extracted for 5 to 10 hours, preferably 7 to 8 hours at 60 to 90 ℃. When the extraction temperature and time are less than the lower limit, the active ingredient may not be extracted, and when the extraction temperature and time are greater than the upper limit, the burnt taste is strong and the nutrient component may be destroyed.
상기 추출용매로는 특별히 한정하는 것은 아니지만, 물, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매를 들 수 있으며, 물로 추출된 추출물이 유기 용매로 추출된 추출물에 비하여 피로개선 효과가 우수하므로 물을 추출용매로 사용하는 것이 바람직하다.The extraction solvent is not particularly limited, but may include water, a lower alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof. Since the extract extracted with water is superior to the extract extracted with an organic solvent, water It is preferable to use as an extraction solvent.
상기와 같이 제조된 구절초 혼합 추출물은 추출물 자체로 이용하거나 사용이 편리하도록 분말화하여 이용할 수 있다. 상기 구절초 혼합 추출물을 분말화하는 방법은 추출물을 감압 농축하여 부피를 줄인 후 동결건조기로 동결건조하여 분말화한다.
The Gujeolcho mixed extract prepared as described above may be used as an extract itself or may be powdered for convenience. The method of powdering the Gujeolcho mixed extract is to reduce the volume by concentrating the extract under reduced pressure, and lyophilize it with a freeze dryer to powder it.
본 발명의 구절초 혼합 추출물은 광의로는 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물을 동물에게 투여할 수 있도록 제형화된 구절초 혼합 가공물, 예컨대, 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 분말도 포함하는 의미를 갖는다. 비록 본 발명에서 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물로 실험을 진행하긴 하였으나, 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 가공물과 같은 형태로도 목적하는 효과를 달성할 수 있음은 당업자라면 예상가능할 것이다.The Gujeolcho mixed extract of the present invention also includes a Gujeolcho mixed product formulated so that a mixture of Gujeolcho flowers, stems and roots can be administered to an animal in a broad sense, such as a mixed powder of Gujeolcho flowers, stems and roots. Has meaning. Although the experiment was conducted with a mixed extract of Gujeolcho flowers, stems and roots in the present invention, it is expected by those skilled in the art that the desired effect can be achieved even in the same form as a mixed processed product of Gujeolcho flowers, stems and roots. It will be possible.
한편, 본 명세서에서 용어 '유효성분으로 함유하는'이란 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 일예로, 상기 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물은 10 내지 1500 ㎍/㎖, 바람직하게는 100 내지 1000 ㎍/㎖의 농도로 사용된다. 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물은 천연물로서 과량 투여하여도 인체에 부작용이 없으므로 본 발명의 조성물 내에 포함되는 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물의 양적 상한은 당업자가 적절한 범위 내에서 선택하여 실시할 수 있다.Meanwhile, in the present specification, the term "containing as an active ingredient" means including an amount sufficient to achieve the efficacy or activity of the mixed extract obtained by mixing Gujeolcho flowers, stems and roots. For example, the mixture of Gujeolcho flowers, stems, and roots is used in a concentration of 10 to 1500 μg/ml, preferably 100 to 1000 μg/ml. The mixture of Gujeolcho flowers, stems, and roots is a natural product and does not have side effects on the human body even when excessive administration is applied. Therefore, the upper limit of the quantity of the mixture of Gujeolcho flowers, stems and roots included in the composition of the present invention is selected within an appropriate range It can be done.
본 발명은 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 유효성분으로 함유하여 피로를 개선시킬 수 있는 식품 조성물을 제공한다.The present invention provides a food composition that can improve fatigue by containing a mixed extract of Gujeolcho flowers, stems and roots as an active ingredient.
본 발명에 따른 식품 조성물은 기능성 식품으로 이용하거나, 각종 식품에 첨가할 수 있다. 본 발명의 조성물을 첨가할 수 있는 식품으로는 예를 들어, 음료류, 알코올 음료류, 과자류, 다이어트바, 유제품, 육류, 초코렛, 피자, 라면, 기타 면류, 껌류, 아이스크림류, 비타민 복합제, 건강보조식품류 등이 있다.The food composition according to the present invention can be used as a functional food or added to various foods. Foods to which the composition of the present invention can be added include, for example, beverages, alcoholic beverages, confectionery, diet bars, dairy products, meat, chocolate, pizza, ramen, other noodles, gum, ice cream, vitamin complexes, health supplements. Etc.
본 발명의 식품 조성물은 유효성분으로서 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 포함하는 혼합물뿐만 아니라, 식품 제조 시에 통상적으로 첨가되는 성분을 포함할 수 있으며, 예를 들어, 단백질, 탄수화물, 지방, 영양소, 조미제 및 향미제를 포함한다. 상술한 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 사이클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 향미제로서 천연 향미제 [타우마틴, 스테비아 추출물 (예를 들어 레바우디오시드 A, 글리시르히진 등]) 및 합성 향미제(사카린, 아스파르탐 등)를 사용할 수 있다. 예컨대, 본 발명의 식품 조성물이 드링크제와 음료류로 제조되는 경우에는 본 발명의 구절초 꽃 추출물 또는 구절초 줄기 추출물을 포함하는 혼합물 이외에 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 및 각종 식물 추출액 등을 추가로 포함시킬 수 있다.The food composition of the present invention may include not only a mixture containing a mixed extract of Gujeolcho flowers, stems and roots as an active ingredient, but also ingredients commonly added during food production, for example, proteins, carbohydrates, Includes fats, nutrients, flavoring and flavoring agents. Examples of the aforementioned carbohydrates include monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, oligosaccharides, and the like; And polysaccharides, for example, common sugars such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents, natural flavoring agents [taumatin, stevia extract (eg, rebaudioside A, glycyrrhizin, etc.]) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used. For example, when the food composition of the present invention is made of drinks and beverages, in addition to the mixture containing the Gujeolcho flower extract or Gujeolcho stem extract of the present invention, citric acid, liquid fructose, sugar, glucose, acetic acid, malic acid, fruit juice, and various plant extracts And the like may additionally be included.
본 발명은 상기 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 유효성분으로 포함하는 피로개선을 위한 식품 조성물을 포함하는 건강기능식품을 제공한다. 건강기능식품이란, 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 포함하는 혼합물을 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡슐화, 분말화, 현탁액 등으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 것을 의미하나, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용시 발생할 수 있는 부작용 등이 없는 장점이 있다. 이와 같이 하여 얻어지는 본 발명의 건강기능식품은, 일상적으로 섭취하는 것이 가능하기 때문에 매우 유용하다. 이와 같은 건강기능식품에 있어서의 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물의 첨가량은, 대상인 건강기능식품의 종류에 따라 달라 일률적으로 규정할 수 없지만, 식품 본래의 맛을 손상시키지 않는 범위에서 첨가하면 되며, 대상 식품에 대하여 통상 0.01 내지 50 중량%, 바람직하기로는 0.1 내지 20 중량%의 범위이다. 또한, 환제, 과립제, 정제 또는 캡슐제 형태의 건강기능식품의 경우에는 통상 0.1 내지 100 중량% 바람직하기로는 0.5 내지 80 중량%의 범위에서 첨가하면 된다. 한 구체예에서, 본 발명의 건강기능식품은 환제, 정제, 캡슐제 또는 음료의 형태일 수 있다.The present invention provides a health functional food comprising a food composition for improving fatigue comprising a mixed extract of Gujeolcho flowers, stems and roots as an active ingredient. Health functional foods are foods prepared by adding a mixture containing a mixed extract of Gujeolcho flowers, stems and roots to food materials such as beverages, teas, spices, gums, confectionery, etc., or by encapsulation, powdering, suspension, etc. However, when ingested, it means that it has a specific effect on health, but unlike general drugs, it has the advantage of not having side effects that may occur when taking the drug for a long time using food as a raw material. The health functional food of the present invention obtained in this way is very useful because it can be consumed on a daily basis. The amount of the mixed extract of Gujeolcho flower, stem, and root mixed in such health functional foods cannot be uniformly regulated depending on the type of health functional food to be applied, but is added within the range that does not damage the original taste of the food. It is sufficient, and is usually in the range of 0.01 to 50% by weight, preferably 0.1 to 20% by weight, based on the target food. In addition, in the case of health functional foods in the form of pills, granules, tablets or capsules, it is usually added in the range of 0.1 to 100% by weight, preferably 0.5 to 80% by weight. In one embodiment, the health functional food of the present invention may be in the form of a pill, tablet, capsule or beverage.
또한, 본 발명은 피로개선을 위한 식품의 제조를 위한 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물의 용도를 제공한다. 상기한 바와 같이 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물은 피로개선을 위한 용도로 이용될 수 있다.In addition, the present invention provides the use of a mixed extract of Gujeolcho flowers, stems and roots for the manufacture of food for improving fatigue. As described above, the mixed extract of Gujeolcho flowers, stems and roots may be used for fatigue improvement.
또한, 본 발명은 포유동물에게 유효량의 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합 추출물을 투여하는 것을 포함하는 피로개선 방법을 제공한다.In addition, the present invention provides a method for improving fatigue comprising administering a mixed extract of Gujeolcho flowers, stems and roots in an effective amount to a mammal.
여기에서 사용된 용어 "포유동물"은 치료, 관찰 또는 실험의 대상인 포유동물을 말하며, 바람직하게는 인간을 말한다.
The term "mammal" as used herein refers to a mammal that is the subject of treatment, observation or experimentation, and preferably refers to a human.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, a preferred embodiment is presented to aid the understanding of the present invention, but the following examples are only illustrative of the present invention, and it is obvious to those skilled in the art that various changes and modifications are possible within the scope and spirit of the present invention, It is natural that such modifications and modifications fall within the appended claims.
실시예 1. 구절초 혼합 추출물 Example 1. Gujeolcho mixed extract
구절초 꽃, 줄기 및 뿌리를 각각 세척하여 동결건조한 후 분쇄하여 각각의 분말을 수득한 후 구절초 꽃 분말, 구절초 줄기 분말 및 구절초 뿌리 분말을 1 : 1.2 : 0.7의 중량비로 혼합하였다. 상기 혼합 분말 100 g과 정제수 900 ml를 혼합하여 80 ℃의 중탕에서 8시간 동안 추출한 후 감압 여과하고 농축 및 동결건조하여 구절초 혼합 추출물 분말을 수득하였다.
Gujeolcho flowers, stems, and roots were washed, freeze-dried, and pulverized to obtain respective powders. Gujeolcho flower powder, Gujeolcho stem powder, and Gujeolcho root powder were mixed in a weight ratio of 1:1.2:0.7. 100 g of the mixed powder and 900 ml of purified water were mixed, extracted for 8 hours in a bath at 80° C., filtered under reduced pressure, concentrated, and freeze-dried to obtain a mixed extract powder of Gujeolcho.
비교예 1. 구절초 꽃 추출물 Comparative Example 1. Gujeolcho flower extract
상기 실시예 1과 동일하게 실시하되, 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물 대신 구절초 꽃만 사용하여 구절초 꽃 추출물 분말을 수득하였다.
It was carried out in the same manner as in Example 1, but instead of a mixture of Gujeolcho flowers, stems and roots, only Gujeolcho flowers were used to obtain Gujeolcho flower extract powder.
비교예 2. 구절초 줄기 추출물 Comparative Example 2. Gujeolcho stem extract
상기 실시예 1과 동일하게 실시하되, 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물 대신 구절초 줄기만 사용하여 구절초 줄기 추출물 분말을 수득하였다.
It was carried out in the same manner as in Example 1, but instead of a mixture of Gujeolcho flowers, stems and roots, only Gujeolcho stems were used to obtain Gujeolcho stem extract powder.
비교예 3. 구절초 뿌리 추출물 Comparative Example 3. Gujeolcho root extract
상기 실시예 1과 동일하게 실시하되, 구절초 꽃, 줄기 및 뿌리를 혼합한 혼합물 대신 구절초 뿌리만 사용하여 구절초 뿌리 추출물 분말을 수득하였다.
It was carried out in the same manner as in Example 1, but instead of a mixture of Gujeolcho flowers, stems, and roots, only Gujeolcho roots were used to obtain Gujeolcho root extract powder.
비교예 4. 함량Comparative Example 4. Content
상기 실시예 1과 동일하게 실시하되, 구절초 꽃, 줄기 및 뿌리를 1 : 0.5 : 3의 중량비로 혼합하여 구절초 혼합 추출물 분말을 수득하였다.
In the same manner as in Example 1, Gujeolcho flowers, stems, and roots were mixed in a weight ratio of 1:0.5:3 to obtain Gujeolcho mixed extract powder.
<시험예><Test Example>
시험예 1. 수율 측정Test Example 1. Yield measurement
실시예 1에 따라 제조된 구절초 혼합 추출물에 대한 수율을 하기 [수학식 1]에 따라 계산하였다.The yield for the Gujeolcho mixed extract prepared according to Example 1 was calculated according to the following [Equation 1].
[수학식 1][Equation 1]
수율(%) = (동결건조 분말의 무게(g) / 시료의 무게(g)) X 100Yield (%) = (Weight of freeze-dried powder (g) / Weight of sample (g))
위 표 1에 나타낸 바와 같이, 본 발명의 실시예 1에 따라 제조된 구절초 혼합 추출물의 수율은 약 12%인 것을 확인하였다.
As shown in Table 1 above, it was confirmed that the yield of the Gujeolcho mixed extract prepared according to Example 1 of the present invention was about 12%.
시험예 2. 세포독성 평가Test Example 2. Cytotoxicity evaluation
실시예 및 비교예에서 제조된 구절초 추출물이 마우스 유래 근아세포(C2C12 cell line)에 미치는 세포독성을 확인하였다.The cytotoxicity of the Gujeolcho extract prepared in Examples and Comparative Examples on mouse-derived myoblasts (C2C12 cell line) was confirmed.
구절초 추출물의 세포독성은 MTT{3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide}assay를 이용하여 분석하였다. 마우스 유래 근아세포에 10% FBS(Fetal bovine serum, 소태아혈청)가 첨가된 DMEM 배지에서 37 ℃ 조건으로 배양시킨 후 배양된 세포를 96-well plate에 10% FBS가 첨가된 DMEM 배지를 사용하여 1X10⁴ cell/ml의 농도로 접종하고 24시간 동안 배양한 다음 각 well에 실시예 1에서 제조된 구절초 혼합 추출물을 DMEM 배지에 1000 μg/mL로 처리하여 24시간 동안 배양하였다. 이후 5 mg/ml 농도의 MTT 시약을 각 well에 10 μL씩 처리한 후 3시간 뒤 배양액을 제거하여 각 well에 DMSO(dimethyl sulfoxide)를 100 μL씩 분주한 후 595 nm에서 흡광도를 측정하였다. The cytotoxicity of Gujeolcho extract was analyzed using MTT{3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide}assay. Mouse-derived myoblasts were cultured in DMEM medium containing 10% FBS (Fetal bovine serum, fetal bovine serum) at 37°C, and then cultured cells were cultured in a 96-well plate using DMEM medium containing 10% FBS. After inoculation at a concentration of 1×10⁴ cell/ml and cultured for 24 hours, the Gujeolcho mixed extract prepared in Example 1 was treated in DMEM medium at 1000 μg/mL in each well and cultured for 24 hours. Thereafter, 10 μL of MTT reagent at a concentration of 5 mg/ml was treated in each well, and after 3 hours, the culture solution was removed, and 100 μL of dimethyl sulfoxide (DMSO) was dispensed into each well, and the absorbance was measured at 595 nm.
[수학식 2][Equation 2]
세포 생존율(%) = (A/B)X100Cell viability (%) = (A/B)X100
A : 열수추출물 처리군의 흡광도A: absorbance of hot water extract treatment group
B : 대조군의 흡광도B: absorbance of the control group
위 표 2에 나타낸 바와 같이, 본 발명의 실시예 1에 따라 제조된 구절초 혼합 추출물 및 비교예 1 내지 4의 추출물은 C2C12 근아세포에서 0 내지 1000 μg/mL의 모든 농도에 따른 세포독성이 나타나지 않는 것으로 확인하였다. As shown in Table 2 above, the Gujeolcho mixed extract prepared according to Example 1 of the present invention and the extracts of Comparative Examples 1 to 4 did not show cytotoxicity according to all concentrations of 0 to 1000 μg/mL in C2C12 myoblasts. Confirmed.
따라서 향후 실험은 높은 농도인 1000 μg/mL를 사용하여 수행하였다.
Therefore, future experiments were performed using a high concentration of 1000 μg/mL.
시험예 3. 산화적 스트레스로부터 세포보호 효과 확인Test Example 3. Cell protection effect confirmation from oxidative stress
실시예 및 비교예에서 제조된 구절초 추출물이 산화적 스트레스로부터 마우스 유래 근아세포(C2C12 cell line)보호 효과를 확인하기 위하여, 실시예 및 비교예의 구절초 추출물의 산화적 스트레스 억제능을 측정하였다. In order to confirm the protective effect of the Gujeolcho extract prepared in Examples and Comparative Examples for protecting mouse-derived myoblasts (C2C12 cell line) from oxidative stress, the antioxidant stress inhibitory ability of Gujeolcho extracts of Examples and Comparative Examples was measured.
산화적 스트레스로부터 근육세포 보호효과는 배양된 세포를 96-well plate에 10% FBS가 첨가된 DMEM 배지를 사용하여 1X10⁴ cell/ml의 농도로 접종하고 24시간 동안 배양한 후, 각 well에 실시예 1에서 제조된 구절초 혼합 추출물을 DMEM 배지에 1000 μg/mL로 1시간 전에 처리하고 H2O2 500 μM를 처리하여 24시간 동안 반응시켜 산화적 스트레스를 유도하였다. 이후 5 mg/ml 농도의 MTT 시약을 각 well에 10 μL씩 처리한 후 3시간 뒤 배양액을 제거하여 각 well에 DMSO(dimethyl sulfoxide)를 100 μL씩 분주한 후 595 nm에서 흡광도를 측정하였다. To protect muscle cells from oxidative stress, cultured cells were inoculated at a concentration of 1X10⁴ cells/ml using DMEM medium added with 10% FBS in a 96-well plate and incubated for 24 hours, followed by examples in each well. The Gujeolcho mixed extract prepared in 1 was treated in DMEM medium at 1000 μg/mL for 1 hour before, and H 2 O 2 500 μM was treated and reacted for 24 hours to induce oxidative stress. Thereafter, 10 μL of MTT reagent at a concentration of 5 mg/ml was treated in each well, and after 3 hours, the culture solution was removed, and 100 μL of dimethyl sulfoxide (DMSO) was dispensed into each well, and the absorbance was measured at 595 nm.
하기 표 3은 근아세포에서 산화적 스트레스로부터 근육세포의 세포 생존율을 측정한 것이며, 하기 표 4는 실시예 및 비교예의 구절초 추출물이 근아세포에서 산화적 스트레스로부터 근육세포 보호효과를 나타낸 것이다.Table 3 below is a measure of the cell survival rate of muscle cells from oxidative stress in myoblasts, and Table 4 below shows the effect of protecting muscle cells from oxidative stress in myoblasts of Gujeolcho extracts of Examples and Comparative Examples.
위 표 3 및 표 4에 나타낸 바와 같이, H2O2는 근육세포에 산화적 스트레스를 유도하여 낮은 세포 생존율을 보였으며, 실시예 1에 따라 제조된 구절초 혼합 추출물(1000 μg/mL) 처리군의 세포 생존율은 75.8%로 H2O2로 유도된 세포손상에 대해 약 19% 유의적인 보호 효과를 나타내었다.As shown in Tables 3 and 4 above, H 2 O 2 showed low cell survival rate by inducing oxidative stress on muscle cells, and Gujeolcho mixed extract prepared according to Example 1 (1000 μg/mL) treated group The cell viability of was 75.8%, which showed a significant protective effect of about 19% against H 2 O 2 induced cell damage.
반면, 비교예 1 내지 4에 따라 제조된 추출물은 H2O2로 유도된 세포손상에 대해 보호 효과를 나타내지 못하는 것으로 확인되었다.On the other hand, it was confirmed that the extracts prepared according to Comparative Examples 1 to 4 did not exhibit a protective effect against cell damage induced by H 2 O 2 .
즉, 실시예 1의 구절초 혼합 추출물은 H2O2로 유도된 산화적 스트레스로부터 근육세포 보호효과가 있음을 확인하였다.
That is, it was confirmed that the mixed extract of Gujeolcho of Example 1 had a protective effect on muscle cells from oxidative stress induced by H 2 O 2 .
시험예 4. 세포내 활성산소 함량 분석 Test Example 4. Analysis of active oxygen content in cells
생체 내에서 유해활성산소의 형성은 산소를 사용하는 과정에서 자연스레 생성된다. 산소는 전자를 획득하기 쉬운 상태가 되어 강력한 산화제가 될 수 있다. 이러한 활성산소종(Reactive oxygen species, ROS) 발생 정도를 DCFH-DA(Dichlorofluorescin diacetate)법을 이용하여 측정하였다. The formation of harmful reactive oxygen species in the body is naturally produced in the process of using oxygen. Oxygen can become a powerful oxidizing agent because it is easy to acquire electrons. The degree of occurrence of these reactive oxygen species (ROS) was measured using the DCFH-DA (Dichlorofluorescin diacetate) method.
산화적 스트레스로부터 발생한 ROS 제거능 효과는 배양된 근육세포를 96-well black plate에 10% FBS가 첨가된 DMEM 배지를 사용하여 1X10⁴ cell/ml의 농도로 접종하고 24시간 동안 배양한 후, 각 well에 실시예 1에서 제조된 구절초 혼합 추출물을 DMEM 배지에 1000 ug/mL로 1시간 전에 처리하고 H2O2 500 uM를 처리하여 2시간 동안 반응시켜 산화적 스트레스를 유도하였다. 이후, 10 uM/ml 농도의 DCFH-DA 시약을 각 well에 20 uL씩 처리하여 30분 후, fluorometer를 사용하여 λ excitation 485 nm, λ emission 535 nm 조건에서 형광도를 측정하였다. The ROS removal effect resulting from oxidative stress was determined by inoculating cultured muscle cells in a 96-well black plate at a concentration of 1X10⁴ cells/ml using DMEM medium with 10% FBS and incubating for 24 hours, and then in each well. The Gujeolcho mixed extract prepared in Example 1 was treated in DMEM medium at 1000 ug/mL for 1 hour before, and H 2 O 2 500 uM was treated and reacted for 2 hours to induce oxidative stress. Thereafter, a DCFH-DA reagent at a concentration of 10 uM/ml was treated with 20 uL in each well, and after 30 minutes, fluorescence was measured under the conditions of λ excitation 485 nm and λ emission 535 nm using a fluorometer.
도 1은 본 발명의 구절초 혼합 추출물을 사용 시 근아세포에서 활성산소에 대한 형광 광도를 나타낸 그래프이다.1 is a graph showing the fluorescence intensity of reactive oxygen species in myoblasts when using the Gujeolcho mixed extract of the present invention.
하기 표 5는 실시예 및 비교예의 추출물을 사용 시 근아세포에서 활성산소에 대한 면적을 나타낸 것이다. Table 5 below shows the area for free radicals in myoblasts when using the extracts of Examples and Comparative Examples.
도 1 및 위 표 5에 나타낸 바와 같이, H2O2는 근육세포에 산화적 스트레스를 유도하였으며 구절초 추출물 생략(H2O2 처리; 0+H2O2)은 대조군에 비해 세포내 ROS 발생양이 유의적으로 증가하였으나, 실시예 1에 따라 제조된 구절초 혼합 추출물(1000 μg/mL)을 처리한 군에서는 구절초 추출물 생략한 군에 비해 ROS 발생양이 유의적으로 감소하는 결과를 확인하였다. 1 and Table 5 above, H 2 O 2 induced oxidative stress in muscle cells, and Gujeolcho extract was omitted (H 2 O 2 process; 0+H 2 O 2 ) significantly increased the amount of intracellular ROS generation compared to the control group, but in the group treated with Gujeolcho mixed extract (1000 μg/mL) prepared according to Example 1, in the group omitting Gujeolcho extract. In comparison, it was confirmed that the amount of ROS was significantly decreased.
반면, 비교예 1 내지 4의 추출물은 구절초 추출물 생략한 군에 비해 ROS 발생양이 감소하지 않는 것을 확인하였다.On the other hand, it was confirmed that the extracts of Comparative Examples 1 to 4 did not decrease the amount of ROS incidence compared to the group omitting the Gujeolcho extract.
즉, 실시예 1의 구절초 혼합 추출물은 H2O2로 유도된 산화적 스트레스로부터 ROS 발생양을 유의적으로 감소시킴으로써 근육세포 보호효과가 있음을 확인하였다.
That is, it was confirmed that the mixed extract of Gujeolcho of Example 1 significantly reduced the amount of ROS generated from oxidative stress induced by H 2 O 2 , thereby having a protective effect on muscle cells.
시험예 5. 항산화 성분 분석Test Example 5. Antioxidant component analysis
5-1. 총 폴리페놀 함량(mgGA/g): Folin-Denis 법을 이용하여 실시예 1에서 제조한 구절초 혼합 추출물의 총 폴리페놀 함량을 측정하였다. 1 mg의 시료에 증류수를 첨가해 1 mL가 되도록 시험용액을 준비하였다. 0.5 mL의 시험용액(1 mg/mL)에 2% Na2CO3 용액 1 mL, Folin-Ciocalteu's 시약 50 μL를 차례로 첨가한 다음 Spectrophotometer로 720 nm에서 흡광도를 측정한 후 측정된 흡광도를 Gallic acid equivalent Standard curve로부터 환산하여 함량으로 나타내었다.5-1. Total polyphenol content (mgGA/g): The total polyphenol content of the Gujeolcho mixed extract prepared in Example 1 was measured using the Folin-Denis method. A test solution was prepared by adding distilled water to 1 mg of sample to make 1 mL. To 0.5 mL of test solution (1 mg/mL), 1 mL of 2% Na 2 CO 3 solution and 50 μL of Folin-Ciocalteu's reagent were sequentially added, and the absorbance was measured at 720 nm with a spectrophotometer, and the measured absorbance was Gallic acid equivalent. Converted from the standard curve and expressed as a content
5-2. 총 플라보노이드 함량(mg Rutin/g): 실시예 1에서 제조한 구절초 혼합 추출물의 총 플라보노이드 함량을 측정하였다. 1 mg의 시료에 증류수를 첨가해 1 mL가 되도록 시험용액을 준비하였다. 1 mL의 시험용액(1 mg/mL)에 5% NaNO2 용액 75 μL를 첨가한 다음 5분간 실온에서 반응시킨 후 10% AlCl3 용액 30 μL와 1M NaOH 200 μL를 가한 다음 Spectrophotometer로 510 nm에서 흡광도를 측정한 후 측정된 흡광도를 Rutin equivalent Standard curve로부터 환산하여 함량으로 나타내었다. 5-2. Total flavonoid content (mg Rutin/g): The total flavonoid content of the Gujeolcho mixed extract prepared in Example 1 was measured. A test solution was prepared by adding distilled water to 1 mg of sample to make 1 mL. After adding 75 μL of 5% NaNO 2 solution to 1 mL of test solution (1 mg/mL), reacting at room temperature for 5 minutes, 30 μL of 10% AlCl 3 solution and 200 μL of 1M NaOH were added, and then at 510 nm with a spectrophotometer. After measuring the absorbance, the measured absorbance was converted from the Rutin equivalent Standard curve and expressed as a content.
위 표 6에 나타낸 바와 같이, 본 발명의 실시예 1에 따라 제조된 구절초 혼합 추출물(1 mg/mL)은 표준물질 gallic acid 대비 45.36 mg GA/g의 폴리페놀 함량을 나타내었으며, 표준물질 rutin 대비 38.18 mg Rutin/g의 플라보노이드 함량을 나타낸 것을 확인하였다.As shown in Table 6 above, the Gujeolcho mixed extract (1 mg/mL) prepared according to Example 1 of the present invention exhibited a polyphenol content of 45.36 mg GA/g compared to the standard gallic acid, compared to the standard substance rutin. It was confirmed that the flavonoid content of 38.18 mg Rutin/g was shown.
반면, 비교예 1 내지 4의 추출물은 실시예 1의 추출물에 비하여 폴리페놀 함량 및 플라보노이드 함량이 낮은 것을 확인하였다.
On the other hand, it was confirmed that the extracts of Comparative Examples 1 to 4 had lower polyphenol content and flavonoid content than the extract of Example 1.
시험예 6. 항산화 활성 확인Test Example 6. Antioxidant activity confirmation
6-1. ABTS 라디칼 소거능 분석: 구절초 추출물의 항산화 활성을 확인하기 위하여 실시예 및 비교예의 추출물에 대해 ABTS{2,2'-azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid)} 라디칼 소거능을 분석하였다. ABTS 라디칼 소거능은 cation decolorization assay를 이용하여 측정하였다. 6-1. ABTS radical scavenging activity analysis: ABTS {2,2'-azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid)} radical scavenging activity was analyzed for the extracts of Examples and Comparative Examples to confirm the antioxidant activity of Gujeolcho extract. . ABTS radical scavenging ability was measured using a cation decolorization assay.
70 ℃ 항온수조 안에서 30분 동안 1 mM의 AAPH{2,2'-azobis(2-amidinopropane)dihydrochloride}와 2.5 mM의 ABTS를 1,000 mL의 PBS에 용해시켜 라디칼을 형성시킨 후, 734 nm에서 흡광도를 측정하여 흡광도 값이 0.65가 되도록 PBS로 희석하였다. 희석된 ABTS 라디칼 용액 0.98 mL에 1 mg의 시료에 증류수를 첨가해 1 mL가 되도록 제조한 시험용액 0.02 mL(1 mg/mL)를 가하여 20분 간 반응시킨 후 흡광도의 변화를 측정하였다. 측정된 흡광도는 비타민 C를 이용한 표준곡선으로부터 환산하여 VCEAC(Vitamin C Equivalent Antioxidant Capacity)로 나타내었다. After dissolving 1 mM AAPH{2,2'-azobis(2-amidinopropane)dihydrochloride} and 2.5 mM ABTS in 1,000 mL of PBS for 30 minutes in a constant temperature bath at 70° C. to form radicals, absorbance at 734 nm It was measured and diluted with PBS so that the absorbance value became 0.65. To 0.98 mL of the diluted ABTS radical solution, 0.02 mL (1 mg/mL) of the test solution prepared to 1 mL by adding distilled water to 1 mg of the sample was added and reacted for 20 minutes, and the change in absorbance was measured. The measured absorbance was converted from a standard curve using vitamin C and expressed as VCEAC (Vitamin C Equivalent Antioxidant Capacity).
6-2. DPPH 라디칼 소거능 분석: 구절초 추출물의 항산화 효과를 확인하기 위하여, 실시예 및 비교예의 추출물에 대해 DPPH(α,α-diphenyl-β-picrylhydrazyl) 라디칼 소거능을 분석하였다. DPPH 라디칼 소거능은 DPPH free radical assay를 변형하여 측정하였다. 6-2. DPPH radical scavenging ability analysis: In order to confirm the antioxidant effect of Gujeolcho extract, DPPH (α,α-diphenyl-β-picrylhydrazyl) radical scavenging ability was analyzed for the extracts of Examples and Comparative Examples. DPPH radical scavenging activity was measured by modifying the DPPH free radical assay.
0.05 mM DPPH 용액 1.45 mL에, 1 mg의 시료에 증류수를 첨가하여 1 mL가 되도록 제조한 시험용액 50 μL(1 mg/mL)를 가하여 암실 상태에서 30분간 반응 시킨 후 흡광도의 변화를 517 nm에서 측정하였다. 측정된 흡광도는 비타민 C를 이용한 표준곡선으로부터 환산하여 VCEAC로 나타내었다.To 1.45 mL of a 0.05 mM DPPH solution, 50 μL (1 mg/mL) of the test solution prepared to 1 mL by adding distilled water to a 1 mg sample was added and reacted for 30 minutes in a dark room, and the change in absorbance was changed at 517 nm. Measured. The measured absorbance was converted from the standard curve using vitamin C and expressed as VCEAC.
위 표 7에 나타낸 바와 같이, 본 발명의 실시예 1에 따라 제조된 구절초 혼합 추출물(1 mg/mL)은 표준물질인 비타민 C의 항산화 활성과 비교하였을 때 30.47 mg VCEAC/g의 free radical 소거활성을 나타내었으며, 표준물질인 비타민 C의 항산화 활성과 비교하였을 때 24.94 mg VCEAC/g의 free radical 소거활성을 나타낸 것을 확인하였다.As shown in Table 7 above, the Gujeolcho mixed extract (1 mg/mL) prepared according to Example 1 of the present invention has a free radical scavenging activity of 30.47 mg VCEAC/g when compared with the antioxidant activity of the standard vitamin C. As compared with the antioxidant activity of vitamin C, which is a standard substance, it was confirmed that the free radical scavenging activity of 24.94 mg VCEAC/g was shown.
반면, 비교예 1 내지 4의 추출물은 실시예 1의 추출물에 비하여 항산화 활성이 낮은 것을 확인하였다.On the other hand, it was confirmed that the extracts of Comparative Examples 1 to 4 had lower antioxidant activity compared to the extract of Example 1.
이상의 결과로부터 실시예 1에 따라 제조된 구절초 혼합 추출물은 우수한 항산화 활성을 가지며, 또한 산화적 스트레스로부터 근육세포 보호효과가 있는 것을 확인하였다.
From the above results, it was confirmed that the mixed extract of Gujeolcho prepared according to Example 1 has excellent antioxidant activity, and also has an effect of protecting muscle cells from oxidative stress.
하기에 본 발명의 분말을 함유하는 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, examples of the formulation of the composition containing the powder of the present invention will be described, but the present invention is not intended to limit it, but is intended to be described in detail.
제제예 1. 기능성 음료의 제조Formulation Example 1. Preparation of functional beverage
실시예 1에서 얻은 혼합 추출물 분말 1,000 mg 1,000 mg of mixed extract powder obtained in Example 1
구연산 1,000 mg1,000 mg citric acid
올리고당 100 g100 g oligosaccharides
매실농축액 2 g2 g of plum concentrate
타우린 1 g1 g taurine
정제수를 가하여 전체 900 mLTotal 900 mL with purified water
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1 시간 동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 L 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 기능성 음료 조성물 제조에 사용한다. After mixing the above ingredients according to a normal health drink manufacturing method, stirring and heating the resulting solution at 85°C for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed and sterilized, and stored in a refrigerator. It is used to prepare the functional beverage composition of the invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.
The composition ratio is composed of ingredients suitable for a relatively preferred beverage in a preferred embodiment, but the mixing ratio may be arbitrarily modified according to regional and ethnic preferences, such as the demand class, the country of demand, and the purpose of use.
Claims (2)
The health functional food for improving fatigue according to claim 1, wherein the Gujeolcho mixed extract is a mixture of flowers, stems and roots of Gujeolcho in a weight ratio of 1: 1-3: 0.5-1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190019342A KR20200101114A (en) | 2019-02-19 | 2019-02-19 | Food composition comprising Chrysanthemum zawadskii var extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190019342A KR20200101114A (en) | 2019-02-19 | 2019-02-19 | Food composition comprising Chrysanthemum zawadskii var extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200101114A true KR20200101114A (en) | 2020-08-27 |
Family
ID=72237629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190019342A KR20200101114A (en) | 2019-02-19 | 2019-02-19 | Food composition comprising Chrysanthemum zawadskii var extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200101114A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024090913A1 (en) * | 2022-10-26 | 2024-05-02 | 주식회사 에이치엘사이언스 | Composition for enhancing exercise performance, comprising, as active ingredient, complex of withania somnifera extract and chrysanthemum zawadskii herbich var. latilobum (maxim.) kitamura extract (asc complex) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180052514A (en) | 2016-11-10 | 2018-05-18 | 대한민국(농촌진흥청장) | A method for manufacturing low temperature aging garlic and composition for antifatigue comprising there of extract |
KR101888756B1 (en) | 2016-10-31 | 2018-09-04 | 어업회사법인 주식회사 해천마 | FOOD COMPOSITION CONTAINING HYDROLYSATE DERIVED FROM Hippocampus abdominalis AND EXTRACT OF RED GINSENG FOR RELIEVING FATIGUE |
-
2019
- 2019-02-19 KR KR1020190019342A patent/KR20200101114A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101888756B1 (en) | 2016-10-31 | 2018-09-04 | 어업회사법인 주식회사 해천마 | FOOD COMPOSITION CONTAINING HYDROLYSATE DERIVED FROM Hippocampus abdominalis AND EXTRACT OF RED GINSENG FOR RELIEVING FATIGUE |
KR20180052514A (en) | 2016-11-10 | 2018-05-18 | 대한민국(농촌진흥청장) | A method for manufacturing low temperature aging garlic and composition for antifatigue comprising there of extract |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024090913A1 (en) * | 2022-10-26 | 2024-05-02 | 주식회사 에이치엘사이언스 | Composition for enhancing exercise performance, comprising, as active ingredient, complex of withania somnifera extract and chrysanthemum zawadskii herbich var. latilobum (maxim.) kitamura extract (asc complex) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101135576B1 (en) | Compositions for prevention and improvement of cancer containing the extracts of native plants as an active ingredient | |
JP6640392B2 (en) | Obesity control composition | |
KR20200101113A (en) | A composition for improving, preventing and treating dermatitis comprising Chrysanthemum zawadskii var extract | |
KR101226824B1 (en) | A composition comprising the extract of Sorghum bicolor L. Moench as an active ingredient for preventing and treating inflammatory disease | |
KR101692889B1 (en) | Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases | |
KR20200101114A (en) | Food composition comprising Chrysanthemum zawadskii var extract | |
KR102366919B1 (en) | Functional health food composition for inhibiting muscle reduction comprising a mixed extract of mulberry twig, Eucommia bark, Acanthopanax, and black bean | |
KR101453455B1 (en) | Pharmaceutical composition or healthy food composition containing Oenanthe javanica extract, fractions thereof or isolated flavonoidic compounds for antioxidant and antiobesity activity | |
KR20170053536A (en) | Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
KR20190001112A (en) | Anti-obesity composition comprising Protaetia brevitarsis seulensis larva extracts | |
KR20140095132A (en) | fermented corni fructus composition with antioxidant activity and method of making the same | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR20110118748A (en) | Compositions for prevention and improvement of cancer containing the extracts of ligularia fischeri var. spiciformis nakai as an active ingredient | |
KR102297398B1 (en) | Composition for health food for improving of respiratory diseases caused by fine dust comprising extract of Liriope platyphylla, Glycyrrhiza uralensis and Aronia as an effective component | |
KR102087165B1 (en) | Pharmaceutical composition for Anti-oxidative or Anti-inflammatory comprising extract processed by Enzymatic hydrolysis of the Bark of Eleutherococcus sessiliflorus | |
KR102531295B1 (en) | Manufacturing method of food composition for immune-enhancing activity comprising juice of Cirsium setidens, and food composition for immune-enhancing activity using thereby | |
KR102302047B1 (en) | Composition for hepatoprotective and ameliorating hangover | |
KR102478971B1 (en) | Composition for bowel movement promotion or diet | |
KR20130082249A (en) | Composition for preventing or improving the metabolic syndrome containing parthenocissus tricuspidata extract | |
KR102355104B1 (en) | Pharmaceutical and functional food composition comprising complex extract of Brassica rapa for prevention or treatment of respiratory disease | |
KR101852032B1 (en) | Beverages for preventing hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
KR102025572B1 (en) | Composition for preventing, ameliorating or treating metabolic diseases comprising mixture of Diospyros lotus leaf and grape fruit stem extract as effective component | |
KR101904819B1 (en) | Composition comprising Fermented Momordica charantia L. and Allium sativum L. using Amyloliquefaciens Bacillus Jis-1 for lowering blood glucose or preventing and treating diabetes mellitus | |
KR20230017739A (en) | Composition for antioxidant or anti-inflammatory composition comprising fermented ingredients of fermented kimchi lactic acid bacteria of Maesaengi extract | |
KR20230166478A (en) | Composition for protecting stomach and intestines comprising Wongam fermented product as effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
X601 | Decision of rejection after re-examination |